電気インピーダンス ミオグラフィー: 神経筋疾患と健康なボランティアの自然史研究
Background:
- Electrical impedance myography (EIM) is a new technique being studied to see if it is helpful in evaluating muscle disorders and nerve disorders. EIM looks at how a mild, painless electrical current travels through muscles. Researchers want to gain experience in using the EIM device. They will collect information on the results of using it on people with and without nerve and muscle diseases, and compare that with information from other standard tests. First, they will test the device on healthy people. Then they will test people with a variety of neuromuscular diseases. Because the test is noninvasive and not painful, researchers will test both children and adults.
Objectives:
- To gain experience using the EIM muscle testing device.
Eligibility:
- Healthy volunteers at least 2 years old.
- Individuals at least 2 years old who have neuromuscular disease.
Design:
- Participants will be screened with a medical history and physical exam.
- Participants will have one 2-3 hour clinic visit. Researchers may request follow-up visits.
- Participants will be tested with the EIM device. The device and small electrodes will be placed on their skin. An electric current will pass through the device, but the participants will not feel this.
- Participants may have an ultrasound test. A gel will be put on their skin, and a device will be moved over the skin.
- Participants may have a nerve test. Electrodes will be placed on their skin, and they will feel a small shock.
- Participants may have a test where a thin needle is inserted in their muscle.
調査の概要
状態
詳細な説明
Study Description: This is a natural history study examining the utility of electrical impedance myography (EIM) device in the evaluation of neuromuscular disorders. This is a novel device so the initial step was to establish reproducibility of the data and expected normative values using the EIM device on healthy volunteers. In neuromuscular disorders, the EIM device will be used to understand the results in different types of neuromuscular disorders. A subset of subjects with neuromuscular disorders are studied serially as preliminary evaluation of its utility as a biomarker in clinical studies. The protocol includes both adult and pediatric subjects.
Objectives:
Primary objective: For subjects with neuromuscular disease, we aim to understand if EIM has utility in differentiating neuromuscular disorders in adult and pediatric subjects. Also, to perform preliminary serial studies to understand the EIM device potential use as biomarker in clinical studies.
For healthy volunteers, the primary objective is reproducibility of results and the range of normative values in adult and pediatric subjects.
Secondary objectives: The three parameters, phase, reactance, resistance will be followed serially as measures of change in pediatric population.
As exploratory outcome measures, we will explore correlations between EIM and ultrasound and other electrodiagnostic methods.
Endpoints:
Primary endpoint:
For healthy volunteers, intra and interrater reliability will be evaluated to determine the utility of EIM as a reproducible biomarker. Normative values will be developed using a range of ages, mixed gender, and race to be used as a basis of comparison with subjects with neuromuscular disorders.
For subjects with neuromuscular disorders, patterns of phase, resistance and reactance in different types of neuromuscular disorders will be evaluated and examined for patterns specific to type of neuromuscular disorder.
Secondary endpoint:
The three parameters, phase, reactance, resistance will be followed serially as measures of change. This will be evaluated in small groups of neuromuscular disorders that are referred to this protocol. A cohort of pediatric healthy volunteers will be followed for two years for comparative data with pediatric subjects with neuromuscular disorders.
Exploratory endpoint:
The EIM phase, muscle ultrasound and possibly MUNIX will be compared in healthy volunteers.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Tanya J Lehky, M.D.
- 電話番号:(301) 496-7428
- メール:lehkyt@ninds.nih.gov
研究連絡先のバックアップ
- 名前:Candida C Silva
- 電話番号:(301) 496-7428
- メール:candida.silva@nih.gov
研究場所
-
-
Maryland
-
Bethesda、Maryland、アメリカ、20892
- 募集
- National Institutes of Health Clinical Center
-
コンタクト:
- For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
- 電話番号:TTY dial 711 800-411-1222
- メール:ccopr@nih.gov
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
- INCLUSION CRITERIA:
HEALTHY VOLUNTEERS-ADULTS
- Healthy adults, male or female, aged 18 years old or older,
- In good general health as evidenced by medical history
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Ability of subject to understand and the willingness to sign a written informed consent document.
HEALTHY VOLUNTEERS-PEDIATRIC
- Healthy children, male or female, age 7-18,
- In good general health as evidenced by medical history
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Ability of subject or Legally Authorized Representative (LAR)) to understand and the willingness to sign a written informed consent document.
SUBJECTS WITH NEUROMUSCULAR DISEASE
Adult and pediatric, male or female, patients with a neuromuscular disorder are eligible even if the exact etiology of the disorder is unknown at the time of enrollment into this study. This will include neuropathy, myopathy and motor neuron disorders. It is expected that the subjects are undergoing appropriate standard diagnostic and genetic work-up outside of this protocol that will later clarify the specific etiology of the disorder. Movement disorders will also be included because of the prior research done on dystonia and EIM.
Inclusion criteria
- Suspected motor neuron disease or
- Suspected myopathy or
- Suspected neuropathy or
- Suspected movement disorders that impair intracortical processes
- Age of 2 years or older
- Ability of subject to sign a written informed consent document.
NIH EMPLOYEES:
NIH employees and staff may participate, however EMG Section, OCD, NINDS, employees may not participate.
EXCLUSION CRITERIA:
HEALTHY VOLUNTEERS-ADULTS
- Medical conditions that require medications that affects the physiological measures being tested. Some conditions that may be excluded are diabetes, kidney and liver disease.
- History of stroke, muscle disorders, peripheral neuropathy or spine surgery
HEALTHY VOLUNTEERS-PEDIATRIC
- Medical conditions that require medications that affects the physiological measures being tested. Some conditions that may be excluded are diabetes, kidney and liver disease.
- History of stroke, muscle disorders, peripheral neuropathy or spine surgery
SUBJECTS WITH NEUROMUSCULAR DISEASE:
No clinical evidence of a neuromuscular disorder on clinical evaluation.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:1/All Subjects
Healthy Volunteers and patients |
EIM device is placed on the muscle and a high frequency current is delivered to the skin. Ultrasound waves to examine the muscles and nerves Small metal disk electrodes attached to wires onto skin to measure how fast nerves conduct electrical impulses and the strength of the connection between nerves and muscles. Thin needle placed into muscles to record electrical activity-adults only |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Patients - EIM measures for a selection of muscles
時間枠:End of study
|
Obtaining measures using EIM device in different types of neuromuscular disorders. |
End of study
|
|
Healthy Volunteers - EIM measures for a selection of muscles with the aim of developing normative values for the NIH EMG lab
時間枠:End of study
|
Obtaining measures using EIM device- reproducibility and normative data |
End of study
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Serial studies in pediatric patients
時間枠:End of study
|
Serial measures of EIM in patients with neuromuscular disorders |
End of study
|
|
Healthy Volunteers - exploratory correlations of ultrasound and electrodiagnostic methods such nerve conduction studies and less likely, EMG
時間枠:End of study
|
Obtaining measures using EIM device and comparing with ultrasound and motor unit number estimation techniques. |
End of study
|
協力者と研究者
捜査官
- 主任研究者:Tanya J Lehky, M.D.、National Institute of Neurological Disorders and Stroke (NINDS)
出版物と役立つリンク
一般刊行物
- Nichols C, Jain MS, Meilleur KG, Wu T, Collins J, Waite MR, Dastgir J, Salman A, Donkervoort S, Duong T, Keller K, Leach ME, Lott DJ, McGuire MN, Nelson L, Rutkowski A, Vuillerot C, Bonnemann CG, Lehky TJ. Electrical impedance myography in individuals with collagen 6 and laminin alpha-2 congenital muscular dystrophy: a cross-sectional and 2-year analysis. Muscle Nerve. 2018 Jan;57(1):54-60. doi: 10.1002/mus.25629. Epub 2017 Apr 25.
- Schwartz DP, Dastgir J, Salman A, Lear B, Bonnemann CG, Lehky TJ. Electrical impedance myography discriminates congenital muscular dystrophy from controls. Muscle Nerve. 2016 Mar;53(3):402-6. doi: 10.1002/mus.24770. Epub 2015 Aug 13.
- Offit MB, Wu T, Floeter MK, Lehky TJ. Electrical impedance myography (EIM) in a natural history study of C9ORF72 mutation carriers. Amyotroph Lateral Scler Frontotemporal Degener. 2020 Aug;21(5-6):445-451. doi: 10.1080/21678421.2020.1752247. Epub 2020 Apr 21.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (推定)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 130165
- 13-N-0165
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
There is no formalized plan to make IPD available of a website. The data from this protocol would be available in anonomyzed format in relationship to publications.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。